Are antioxidants or supplements protective for age-related macular degeneration?
S. West, S. Vitale, J. Hallfrisch, B. Munoz, D. Muller, S. Bressler and N. M. Bressler
Dana Center for Preventive Ophthalmology, Johns Hopkins Hospital, Baltimore, Md.
OBJECTIVES: The relationships between fasting plasma levels of retinol,
ascorbic acid, alpha-tochopherol, and beta-carotene and age-related macular
degeneration (AMD) were studied in a population enrolled in the Baltimore
Longitudinal Study of Aging (BLSA), in which most of the data were
collected 2 or more years before assessment of macular status. DESIGN: A
total of 976 participants in the study were scheduled for a biennial
examination from January 1988 through January 1, 1990, which included
taking lens and macular photographs. A total of 827 (85%) of the
participants had fundus photographs taken, and most plasma data were
available for 82% of those subjects with fundus photographs. Age-related
macular degeneration was defined as neovascular changes, geographic and
nongeographic atrophy, large or confluent drusen, or hyperpigmentation. A
total of 226 cases of AMD were available for analysis. RESULTS: Logistic
regression analyses suggested that alpha-tocopherol was associated with a
protective effect for AMD, adjusted for age, sex, and nuclear opacity. An
antioxidant index, including ascorbic acid, alpha-tocopherol, and
beta-carotene, was also protective for AMD. Our conclusions must be
tempered with the knowledge that the population under study was basically
well nourished, and few individuals had any clinically deficient status.
The study cannot exclude the possibility that quite low levels of
micronutrients, lower than those observed in this study, might be risk
factors for AMD. CONCLUSIONS: The data suggest a protective effect for AMD
of high plasma values of alpha-tocopherol. An antioxidant index, composed
of plasma ascorbic acid, alpha-tocopherol, and beta-carotene, was also
protective. The use of vitamin supplements to prevent AMD is not supported
by these data, which showed no protective effect of vitamin use.
Current Concepts in the Pathogenesis of Age-Related Macular Degeneration
Zarbin
Arch Ophthalmol 2004;122:598-614.
ABSTRACT
| FULL TEXT
Prevention of age related macular degeneration
Hall and Gale
BMJ 2002;325:1-2.
FULL TEXT
Vitamin E supplementation and macular degeneration: randomised controlled trial
Taylor et al.
BMJ 2002;325:11-11.
ABSTRACT
| FULL TEXT
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2001;119:1417-1436.
ABSTRACT
| FULL TEXT
Risk Factors for Age-Related Maculopathy: The Visual Impairment Project
McCarty et al.
Arch Ophthalmol 2001;119:1455-1462.
ABSTRACT
| FULL TEXT
Lutein and Zeaxanthin in the Diet and Serum and Their Relation to Age-related Maculopathy in the Third National Health and Nutrition Examination Survey
Marse-Perlman et al.
Am J Epidemiol 2001;153:424-432.
ABSTRACT
| FULL TEXT
Hypertension, Cardiovascular Disease, and Age-Related Macular Degeneration
Hyman et al.
Arch Ophthalmol 2000;118:351-358.
ABSTRACT
| FULL TEXT
Age-related Macular Degeneration and Antioxidant Status in the POLA Study
Delcourt et al.
Arch Ophthalmol 1999;117:1384-1390.
ABSTRACT
| FULL TEXT
TIMP-3 in Bruch’s Membrane: Changes during Aging and in Age-Related Macular Degeneration
Kamei and Hollyfield
IOVS 1999;40:2367-2375.
ABSTRACT
| FULL TEXT
Macular pigment and age related macular degeneration
BEATTY et al.
Br. J. Ophthalmol. 1999;83:867-877.
FULL TEXT
Correlation Between Age-related Macular Degeneration and Pseudoexfoliation Syndrome in the Population of Crete (Greece)
Kozobolis et al.
Arch Ophthalmol 1999;117:664-669.
ABSTRACT
| FULL TEXT
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes
Sommerburg et al.
Br. J. Ophthalmol. 1998;82:907-910.
ABSTRACT
| FULL TEXT
Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan
Tamakoshi et al.
Br. J. Ophthalmol. 1997;81:901-904.
ABSTRACT
| FULL TEXT